February 4, 2020
Bayer Yakuhin and Nippon Kayaku said on February 3 that they have inked a copromotion agreement in Japan for Nubeqa (darolutamide), the German drug maker’s prostate cancer treatment approved last month. Under the pact, the two companies will jointly run...read more